- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,457,135
- Total 13F shares
- 12,428,895
- Share change
- -488,458
- Total reported value
- $114,822,764
- Put/Call ratio
- 13%
- Price per share
- $9.24
- Number of holders
- 64
- Value change
- -$4,446,429
- Number of buys
- 29
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M96088105:
Top shareholders of URGN - UroGen Pharma Ltd. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ran Nussbaum |
3/4/5
|
Director |
—
class O/S missing
|
1,485,168
|
$26,747,876 | — | 21 Oct 2022 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
6%
|
2,919,003
|
$25,891,557 | — | 31 Dec 2022 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
2.7%
|
1,304,947
|
$11,574,880 | — | 31 Dec 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.2%
|
1,060,000
|
$9,402,200 | — | 31 Dec 2022 | |
| Harel Insurance Investments & Financial Services Ltd. |
13F
|
Company |
2.1%
|
1,025,560
|
$9,097,000 | — | 31 Dec 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.8%
|
857,464
|
$7,605,706 | — | 31 Dec 2022 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
1.4%
|
698,302
|
$6,194,000 | — | 31 Dec 2022 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.2%
|
560,000
|
$4,967,200 | — | 31 Dec 2022 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
1.1%
|
533,139
|
$4,728,943 | — | 31 Dec 2022 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
1.1%
|
529,388
|
$4,696,000 | — | 31 Dec 2022 | |
| Opaleye Management Inc. |
13F
|
Company |
1%
|
488,656
|
$4,334,379 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.8%
|
389,175
|
$3,451,982 | — | 31 Dec 2022 | |
| Laurion Capital Management LP |
13F
|
Company |
0.79%
|
380,600
|
$3,375,922 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.72%
|
349,270
|
$3,098,025 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
277,248
|
$2,459,000 | — | 31 Dec 2022 | |
| ARK Investment Management LLC |
13F
|
Company |
0.41%
|
196,938
|
$1,746,840 | — | 31 Dec 2022 | |
| MEITAV INVESTMENT HOUSE LTD |
13F
|
Company |
0.28%
|
136,835
|
$1,183,934 | — | 31 Dec 2022 | |
| Cerity Partners LLC |
13F
|
Company |
0.26%
|
125,226
|
$1,110,755 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
120,476
|
$1,068,622 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.23%
|
112,590
|
$998,673 | — | 31 Dec 2022 | |
| Annandale Capital, LLC |
13F
|
Company |
0.17%
|
84,331
|
$748,000 | — | 31 Dec 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.17%
|
81,007
|
$718,000 | — | 31 Dec 2022 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.15%
|
72,931
|
$646,898 | — | 31 Dec 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
54,615
|
$484,435 | — | 31 Dec 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
51,200
|
$454,144 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
49,149
|
$435,953 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
48,937
|
$434,071 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
43,300
|
$384,000 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
38,972
|
$345,682 | — | 31 Dec 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.08%
|
38,603
|
$342,409 | — | 31 Dec 2022 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.08%
|
37,000
|
$328,190 | — | 31 Dec 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.06%
|
31,046
|
$275,000 | — | 31 Dec 2022 | |
| BBR PARTNERS, LLC |
13F
|
Company |
0.05%
|
26,000
|
$230,620 | — | 31 Dec 2022 | |
| Palo Alto Investors LP |
13F
|
Company |
0.05%
|
24,500
|
$217,315 | — | 31 Dec 2022 | |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. |
13F
|
Company |
0.05%
|
25,330
|
$212,421 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
23,475
|
$208,223 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
22,675
|
$201,127 | — | 31 Dec 2022 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.05%
|
22,604
|
$200,497 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
21,821
|
$193,552 | — | 31 Dec 2022 | |
| Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD |
13F
|
Company |
0.05%
|
21,823
|
$183,010 | — | 31 Dec 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
16,893
|
$149,841 | — | 31 Dec 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.03%
|
14,887
|
$132,000 | — | 31 Dec 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
14,599
|
$129,493 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
14,376
|
$127,000 | — | 31 Dec 2022 | |
| Man Group plc |
13F
|
Company |
0.03%
|
14,300
|
$126,841 | — | 31 Dec 2022 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.03%
|
14,279
|
$126,655 | — | 31 Dec 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
11,139
|
$98,803 | — | 31 Dec 2022 | |
| Molly Henderson |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
42,748
mixed-class rows
|
$94,516 | — | 31 Jan 2022 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.02%
|
10,511
|
$93,233 | — | 31 Dec 2022 | |
| Ethos Financial Group, LLC |
13F
|
Company |
0.02%
|
10,500
|
$93,135 | — | 31 Dec 2022 |
Institutional Holders of UroGen Pharma Ltd. - Common Stock (URGN) as of Q1 2023
As of 31 Mar 2023,
UroGen Pharma Ltd. - Common Stock (URGN) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,428,895 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., CREDIT SUISSE AG/, Harel Insurance Investments & Financial Services Ltd., RTW INVESTMENTS, LP, Stonepine Capital Management, LLC, Migdal Insurance & Financial Holdings Ltd., Clal Insurance Enterprises Holdings Ltd, Opaleye Management Inc., Wildcat Capital Management, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
63
Q1 2023 holders
64
Holder diff
1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.